By Friday, Silicon Valley Bank became pretty much a household name, even by the many who’d never previously heard of, or cared, about it. The Silicon Valley Bank, the California bank subsidiary ...
Tag: Bret Jensen
Time to Hunker Down as SVB Financial Exposes a Growing Number of Naked Swimmers
Some fears of financial contagion crept into the market on Thursday. SVB Financial Group (SIVB) plunged 60% during the trading day and is down big again Friday. SIVB is the parent of Silicon Valley Ba...
This Pharma Is Starting to Recover Nicely
Like so many biopharma stocks, Aurinia Pharmaceuticals (AUPH) was in need of care over much of 2022. But things are now looking better for the company and the shares have started to rebound. The stoc...
If Stocks Zap Your Portfolio, Follow the Path of Least Resistance
I’m charged up about energy. I have increased my exposure here over the past couple of weeks, despite the likelihood of a recession. Several reasons exist for my outlook for the sector. For one,...
This Trade Might Just Knock Your Socks Off
Let’s see how elastic the shares of Hanesbrands Inc. (HBI) are…. The company is best known for underwear — the stock came up in a conversation on Doug Kass’ Daily Diary on Rea...
This Small Pharma Company Could Develop Into a Nice Trade
GlycoMimetics (GLYC) is a clinical-stage drug developer aiming to create what’s called glycobiology-based therapies for cancers. This one has a catch, however. It’s a small biotech name. ...
Can You Picture a Stock Coming Back From the Dead?
Can we bring ‘”dead money” back to life? I think I’ve got a trade that could. I’m looking at GoPro (GRPO) as dead money in the coming quarters, as I expect this equity t...
I’m Going to Propose a Trade Relationship With LOVE
I’ve fallen for a former pandemic star. The Lovesac Company (LOVE) has seen its share price shed approximately three-quarters from its all-time highs. Like many other retailers, Lovesac overest...
As Temps Drop, This Energy Play Should Be a ‘Peak’ Performer
The “Bomb Cyclone” that was slated to hit the country during the holidays seems an appropriate way to end 2022, which has brought little but bad tidings for investors. The artic blast has ...
I’m a Small-Cap Guy, but Disney, Wells Fargo Suddenly Look Entertaining
Outside of energy, investors have found few safe-havens over the past 12 months. The Nasdaq is down over 30% in 2022 and mega caps like Amazon (AMZN) , Tesla (TSLA) and Alphabet (GOOGL) have all tak...
I’m Going to Give This Biotech Another Shot
Dynavax Technologies (DVAX) has spent 2022 building up its cash balance as the biotech raked in revenues from its adjuvant that’s used by several Covid vaccine makers, primarily in Europe. In ad...
Free Cash Flow Is Key to Business Survival, and It’s Why I Like These 2 Stocks
I have learned many things running my own small business over the last decade and a half. One of the most critical is the importance of these three words — free cash flow — to the success ...
This Biopharma ‘Fits the Bill’ as a Growth Play
With the economy looking like it is heading towards recession in 2023, reliable growth names with reasonable valuations are in short supply in the current market. One name that fits that bill is a bio...
Normally I Would Shun This Stock, But Now It’s a ‘Smart’ Option
This is the type of stock I have been avoiding like the plague throughout this year: A name that is delivering stellar revenue growth, but has not achieved profitability yet. It’s SmartSheet (SM...
These 2 Value Stocks Are Cheaper Than They Appear
Growth stocks have taken it on the chin throughout 2022 as interest rates have moved relentlessly higher. Even the old FAANG stocks that led the rally for most of 2021 have not been immune. The highes...
Here’s the Inevitable Outcome From the Fed’s Monetary Tightening
On Wednesday the Federal Reserve hiked the Fed Funds rate by another 75bps. Stocks initially rallied as the statement that accompanied the announcement was interpreted to be ‘dovish’. Howe...
2 New Oncology Focused Small-Cap Biotechs to Keep an Eye On
The biotech sector has held up better than one would expect during the carnage and volatility in the markets over the past couple of months. The lows this sector made in mid-June have formed a firm fl...
I’m Lassoing in a ‘Cowboy’ Trade in Oil
In my hunt for energy names, I’m taking the lead from the owner of the Dallas Cowboys. I’m lassoing in Comstock Resources, Inc. (CRK) . This Frisco, Texas-based independent natural gas pr...
This Infection-Fighting Biotech Is Recovering Nicely
The stock and fortunes of antibiotic-developer Spero Therapeutics (SPRO) looked like they were about to get flushed down the toilet … until last week. The company’s primary and only signi...
2 Companies Where Insiders Have Bought Mass Quantities of Their Shares
Equities over the past week and a half have started to give back some of their gains from the large rebound off their mid-June lows. Some profit taking off that rally is understandable given the curre...
2 Companies Where Insiders Are Gobbling Up Shares
Insiders used the rally in the markets in July to take some money off the table it would seem. The ratio of insider selling compared to insider buying moved to its highest level in 2022. Given the unc...
For Smith & Wesson, Load, Cock and Fire Another Round
It’s time for another round of Smith & Wesson (SWBI) . I targeted this iconic gunmaker in December and showed why my covered-call strategy appeared to hold some firepower. The shares got kno...
I’m ‘Following Up’ on a Biotech Trade With Attractive Potential
Just before noon ET on Friday, May 27, Doug Kass posted the following in his Daily Diary on Real Money Pro: “I added to SPDR S&P Biotech ETF (XBI) this morning. And I sold some attractivel...